<DOC>
	<DOCNO>NCT03060512</DOCNO>
	<brief_summary>The purpose study determine whether patient opioid induced constipation prefer treatment naloxegol ( Movantik ) Polyethylene Glycol 3350 .</brief_summary>
	<brief_title>To Evaluate Patient Preference Movantik Polyethylene Glycol 3350 Opioid Induced Constipation</brief_title>
	<detailed_description>This study prospective , randomize , open-label crossover study consist 1-week washout period , 2-week treatment period , another 1-week washout final 2-week treatment period . The study ass overall patient preference Movantik versus Polyethylene Glycol 3350 treatment opioid-induced constipation . This study also evaluate reason patient preference ( among subject indicate preference ) , patient global impression change , change bowel function treatment period measure Bowel Function Index . Patient 's bowel movement diary also collect study .</detailed_description>
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Naloxegol</mesh_term>
	<mesh_term>Polyethylene glycol 3350</mesh_term>
	<criteria>Male female age ≥18 &lt; 85 year Selfreported active symptom OIC ( Opioid Induced Constipation ) base component Rome IV criterion screen . Patients least 2 follow : &lt; 3 SBMs ( Spontaneous Bowel Movements ) per week Straining &gt; 25 % defecation Sensation incomplete evacuation &gt; 25 % defecation Lumpy hard stool &gt; 25 % defecation Sensation anorectal obstruction/blockage &gt; 25 % defecation Confirmed OIC BFI ( Bowel Function Index ) ≥30 Stable maintenance opioid regimen consist total daily dose least 30 mg oral morphine , equivalent 1 opioid therapy Willingness stop laxative bowel regimen specify rescue medication Pain related cancer history cancer within 5 year Current constipation chronic constipation cause related use opioids History rectal evacuation disorder , surgery procedure potentially affect pelvic floor function ; requirement use manual maneuver facilitate bowel movement Evidence significant GI structural abnormality , acute chronic GI condition could post risk patient confound study result Recent surgery may affect GI motility increase risk bowel obstruction perforation Severe hepatic impairment Moderate severe renal impairment Condition may affect permeability bloodbrain barrier Concomitantly use strong moderate CYP3A4 inhibitor strong CYP3A4 inducer Any significant and/or progressive medical , surgical , psychiatric , mental health condition significant laboratory finding could increase risk participation study affect interpretation study data determine Investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>84 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Opioid Induced constipation ,</keyword>
	<keyword>constipation ,</keyword>
	<keyword>laxative ,</keyword>
	<keyword>bowel movement ,</keyword>
	<keyword>Movantik ,</keyword>
	<keyword>Naloxegol</keyword>
</DOC>